197A — TAUNS Laboratories Share Price
0.000.00%
Last trade - 00:00- ¥58bn
- ¥63bn
- ¥18bn
- 88
- 57
- 70
- 85
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 8.94 | ||
| PEG Ratio (f) | 16.19 | ||
| EPS Growth (f) | 0.56% | ||
| Dividend Yield (f) | 5.98% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.09 | ||
| Price to Tang. Book | 3.96 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.78 | ||
| EV to EBITDA | 6.07 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 34.09% | ||
| Return on Equity | 41.4% | ||
| Operating Margin | 46.42% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | n/a | n/a | 17,456.99 | 15,673.1 | 18,434.86 | 18,895 | 18,529 | 2.76% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | -48.72 | +67.31 | +11.21 | -0.66 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Tauns Laboratories Inc is a Japan-based company engaged in the business of developing, manufacturing and marketing in vitro diagnostic products and research reagents. The Company operates its business in the in vitro diagnostic products business segment. The Company’s main product is antigen test kit that uses immunochromatography to enable rapid diagnosis at the patient's side without the need for special equipment. The products include ImunoAce Flu, ImunoAce SARSCoV-2 II, ImunoAce SARSCoV-2 Saliva, ImunoAce SARSCoV-2/Flu, ImunoAce Adeno, ImunoAce Strep A Neo, ImunoAce hMPV, ImunoAce Mycopiasma, ImunoAce RSV Neo and ImunoAce Noro.
Directors
- Last Annual
- June 30th, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- April 14th, 2016
- Public Since
- June 20th, 2024
- No. of Shareholders
- 17,071
- No. of Employees
- 271
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 102,391,025
- Address
- 761-1, Kamishima, IZUNOKUNI-SHI, 410-2325
- Web
- https://www.tauns.co.jp/
- Phone
- +81 558768181
- Auditors
- Ernst & Young ShinNihon LLC
Upcoming Events for 197A
Dividend For 197A.T - 12.0000 JPY
Similar to 197A
Alfresa Holdings
Tokyo Stock Exchange
Asahi Intecc Co
Tokyo Stock Exchange
Aso International
Tokyo Stock Exchange
As One
Tokyo Stock Exchange
Atect
Tokyo Stock Exchange
FAQ
What is the TAUNS Laboratories share price?
As of Today at 23:35 UTC, shares in TAUNS Laboratories are trading at ¥534. This share price information is delayed by 15 minutes.
How has the TAUNS Laboratories share price performed this year?
Shares in TAUNS Laboratories last closed at ¥534 and the price had moved by over the past 365 days. In terms of relative price strength the TAUNS Laboratories share price has matched the Nikkei 225 Index by over the past year.
What are the analyst and broker recommendations for TAUNS Laboratories?
The overall consensus recommendation for TAUNS Laboratories is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the TAUNS Laboratories dividend yield?
The TAUNS Laboratories dividend yield is 3.12% based on the trailing twelve month period.
Does TAUNS Laboratories pay a dividend?
Last year, TAUNS Laboratories paid a total dividend of ¥17, and it currently has a trailing dividend yield of 3.12%.Looking ahead, shares in TAUNS Laboratories are due to go ex-dividend on 2025-06-27 and the next dividend pay date is 2025-09-01.
When does TAUNS Laboratories next pay dividends?
TAUNS Laboratories are due to go ex-dividend on 2025-06-27 and the next dividend pay date is 2025-09-01. The historic dividend yield on TAUNS Laboratories shares is currently 3.12%.
How do I buy TAUNS Laboratories shares?
To buy shares in TAUNS Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of TAUNS Laboratories?
As of the previous close price of ¥534, shares in TAUNS Laboratories had a market capitalisation of ¥55bn.
Where are TAUNS Laboratories shares listed?
Here are the trading details for TAUNS Laboratories:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 197A
What kind of share is TAUNS Laboratories?
Based on an overall assessment of its quality, value and momentum TAUNS Laboratories is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a TAUNS Laboratories share price forecast for 2025?
The analyst consensus target price for shares in TAUNS Laboratories is ¥710. That is 32.96% above the last closing price of ¥534.
Analysts covering TAUNS Laboratories currently have a consensus Earnings Per Share (EPS) forecast of ¥60 for the next financial year.
Find out moreWhat is the trend in the TAUNS Laboratories share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like TAUNS Laboratories. Over the past six months, its share price has underperformed the Nikkei 225 Index by -1.95%.
As of the last closing price of ¥534, shares in TAUNS Laboratories were trading -0.26% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the TAUNS Laboratories PE Ratio?
The TAUNS Laboratories PE ratio based on its reported earnings over the past 12 months is 8.94. The shares last closed at ¥534.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of TAUNS Laboratories?
We do not have data on TAUNS Laboratories' directors